학술논문

1109O - A phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): Results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
Document Type
Abstract
Source
In Annals of Oncology October 2019 30 Supplement 5:v449-v450
Subject
Language
ISSN
0923-7534